ArticleFrontiers in pediatrics2025
Perceptions of oral corticosteroid use for children with asthma in a survey of US caregivers.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Oral corticosteroids (OCS) are an essential component of asthma treatment, but their long-term effects can be serious and cumulative. Potentially serious effects include adrenal suppression and psychological effects. To mitigate side effects, OCS use should be minimized. A survey of caregivers in the US was conducted to determine their perceptions of OCS use for their child with asthma. Methods: Individuals who participated in US consumer research panels were invited to complete an online cross-sectional survey from October-November 2023. Eligible participants were caregivers of a child ages 6-17 years currently being treated for asthma by a healthcare provider and who had experienced an asthma attack, flare or exacerbation (AAFE) in the past 12 months. Results: Caregivers ( Conclusions: OCS therapy is often used for AAFE and is perceived by caregivers as effective and safe. Caregivers and healthcare providers should be educated about side effects and the importance of optimizing asthma treatment to reduce OCS use.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.